Botulinum toxin in the management of acquired motor fusion deficiency

Ramesh Murthy; Siddharth Kesarwani

doi:10.4103/0301-4738.57162

Botulinum toxin in the management of acquired motor fusion deficiency

Indian J Ophthalmol. 2009 Nov-Dec;57(6):463-4. doi: 10.4103/0301-4738.57162.

Authors

Ramesh Murthy¹, Siddharth Kesarwani

Affiliation

¹ Department of Pediatric Ophthalmology and Strabismus, and Oculoplasty, Orbital diseases and Ocular Oncology, LV Prasad Eye Institute, Hyderabad, India. drrameshmurthy@gmail.com

Abstract

Acquired disruption of motor fusion is a rare condition characterized by intractable diplopia. Management of these patients is extremely difficult. Prisms in any combination or even surgery may not help relieve their symptoms. We describe a longstanding case of acquired motor fusion disruption which was managed successfully with botulinum toxin injection.

Publication types

Case Reports

MeSH terms

Adult
Botulinum Toxins, Type A / administration & dosage*
Depth Perception / physiology
Diplopia / complications
Diplopia / drug therapy*
Diplopia / physiopathology
Electromyography
Eye Movements / drug effects
Eye Movements / physiology
Female
Humans
Injections, Intramuscular
Neuromuscular Agents / administration & dosage*
Ocular Motility Disorders / complications
Ocular Motility Disorders / drug therapy*
Ocular Motility Disorders / physiopathology
Oculomotor Muscles
Strabismus / complications
Strabismus / drug therapy*
Strabismus / physiopathology
Visual Acuity

Substances

Neuromuscular Agents
Botulinum Toxins, Type A